Skip to main content
Equibles

Allworth Financial LP

Position in NVCT — Nuvectis Pharma, Inc.

CIK 1555170 FOLSOM, CA
Back to NVCT Full portfolio

Position in NVCT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,526
+$1,519 QoQ
Shares Held
83
+8200.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 82 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Allworth Financial LP holds $18,666,310 across 285 Biotechnology names. NVCT ranks #213 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 37,664 $2,947,961
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,487 $2,228,827
3 MDGL
Madrigal Pharmaceuticals, Inc.
 3,562 $1,912,615
4 REGN
Regeneron Pharmaceuticals, Inc.
 2,530 $1,577,556
5 INCY
Incyte Corp
 5,182 $587,431
6 EXEL
Exelixis, Inc.
 10,562 $574,678
7 CRSP
CRISPR Therapeutics AG
 10,089 $550,254
8 RVMD
Revolution Medicines, Inc.
 2,240 $419,507

All Filings in NVCT

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,526 83
2026-03-31 $7 1